Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Download CSV

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,289 authorised products are in this register. Synced 26 Oct 2026, 03:27 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Trosyl 283 mg/ml Nail Solution PPA0465/247/001

Tioconazole

PCO Manufacturing Ltd.

—

Trosyl 283 mg/ml Nail Solution PPA1463/169/001

Tioconazole

IMED Healthcare Ltd.,

—

Trulicity 0.75 mg Solution for injection EU/1/14/956/001-005

Dulaglutide

Eli Lilly Nederland B.V.

—

Trulicity 1.5 mg Solution for injection EU/1/14/956/006-010

Dulaglutide

Eli Lilly Nederland B.V.

—

Trulicity 3 mg Solution for injection EU/1/14/956/011-0013

Dulaglutide

Eli Lilly Nederland B.V.

—

Trulicity 4.5 mg Solution for injection EU/1/14/956/014-0016

Dulaglutide

Eli Lilly Nederland B.V.

—

Trumenba suspension for injection in pre-filled syringe. Meningococcal group B vaccine (recombinant, adsorbed). EU/1/17/1187/001-006

Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family a), Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family b)

Pfizer Europe MA EEIG

—

Truoxin I.V. 200mg/100ml solution for infusion PA1217/002/001

Ciprofloxacin

Hikma Farmacêutica (Portugal) S.A.

Marketed

Truoxin I.V. 400 mg/200 ml solution for infusion PA1217/002/002

Ciprofloxacin

Hikma Farmacêutica (Portugal) S.A.

Marketed

TRUQAP 160 mg film-coated tablets EU/1/24/1820/001

Capivasertib

AstraZeneca AB

—

TRUQAP 200 mg film-coated tablets EU/1/24/1820/002

Capivasertib

AstraZeneca AB

—

Trusitev SR 2 mg Prolonged-release Capsules, hard PA0749/191/001

Tolterodine tartrate

Teva Pharma B.V.

Marketed

Trusitev SR 4 mg Prolonged-release Capsules, hard PA0749/191/002

Tolterodine tartrate

Teva Pharma B.V.

Marketed

TRUSOPT 20 mg/ml eye drops, solution PA0879/004/001

Dorzolamide hydrochloride

Santen OY

Marketed

TRUSOPT Preservative-Free 20 mg/ml eye drops, solution in single-dose container PA0879/004/002

Dorzolamide hydrochloride

Santen OY

Marketed

Truvada 200 mg/245 mg film-coated tablets EU/1/04/305/001-002

Emtricitabine, Tenofovir disoproxil

Gilead Sciences Ireland UC

—

Truvelog Mix 30 EU/1/22/1639/001-005

Insulin aspart

Sanofi Winthrop Industrie

—

Truxima 100 mg concentrate for solution for infusion EU/1/16/1167/002

Celltrion Healthcare Hungary Kft.

—

Truxima 500 mg concentrate for solution for infusion EU/1/16/1167/001

Rituximab

Celltrion Healthcare Hungary Kft.

—

Trydonis 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution EU/1/18/1274/001-005

Beclometasone dipropionate, Formoterol fumarate dihydrate, GLYCOPYRRONIUM

Chiesi Farmaceutici S.p.A.

—

Trydonis 88 micrograms/5 micrograms/9 micrograms inhalation powder EU/1/18/1274/006-008

Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide

Chiesi Farmaceutici S.p.A.

—

Tuberculin PPD RT23 AJV 2 T.U./0.1 mL, solution for injection PA2160/004/001

Tuberculin ppd

AJ Vaccines A/S

Marketed

TUKYSA 150 mg film-coated tablets EU/1/20/1526/002

Tucatinib

Pfizer Europe MA EEIG

—

TUKYSA 50 mg film-coated tablets EU/1/20/1526/001

Tucatinib

Pfizer Europe MA EEIG

—

Tuyory 162 mg solution for injection in pre-filled pen EU/1/26/2022/009-010

Tocilizumab

Gedeon Richter Plc

—

Tuyory 162 mg solution for injection in pre-filled syringe EU/1/26/2022/007-008

Tocilizumab

Gedeon Richter Plc

—

Tuyory 20 mg/mL concentrate for solution for infusion EU/1/26/2022/001-006

Tocilizumab

Gedeon Richter Plc

—

Tuznue 150 mg Powder for concentrate for solution for infusion EU/1/24/1864/001

Trastuzumab

Prestige Biopharma Belgium

—

Tuznue 420 mg Powder for concentrate for solution for infusion EU/1/24/1864/002

Trastuzumab

Prestige Biopharma Belgium

—

Tuzulby 20 mg prolonged-release chewable tablets EU/1/24/1907/001

Methylphenidate hydrochloride

Neuraxpharm Pharmaceuticals S.L.

—

Tuzulby 30 mg prolonged-release chewable tablets EU/1/24/1907/002

Methylphenidate hydrochloride

Neuraxpharm Pharmaceuticals S.L.

—

Tuzulby 40 mg prolonged-release chewable tablets EU/1/24/1907/003

Methylphenidate hydrochloride

Neuraxpharm Pharmaceuticals S.L.

—

Twilev 10 mg/5 mg film-coated tablets PA0865/022/003

Ramipril, Nebivolol hydrochloride

Menarini International Operations Luxembourg S.A.

Not marketed

Twilev 2.5 mg/5 mg film-coated tablets PA0865/022/001

Ramipril, Nebivolol hydrochloride

Menarini International Operations Luxembourg S.A.

Not marketed

Twilev 5 mg/5 mg film-coated tablets PA0865/022/002

Ramipril, Nebivolol hydrochloride

Menarini International Operations Luxembourg S.A.

Not marketed

Twinrix Adult EU/1/96/020/004